Organon & Co (NYSE: OGN) is -3.82% lower on its value in year-to-date trading and has touched a low of $13.87 and a high of $23.10 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The OGN stock was last observed hovering at around $14.91 in the last trading session, with the day’s loss setting it -0.56%.
Currently trading at $14.35, the stock is -5.55% and -6.52% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.02 million and changing -3.76% at the moment leaves the stock -21.61% off its SMA200. OGN registered -19.52% loss for a year compared to 6-month loss of -36.14%.
The stock witnessed a -10.14% gain in the last 1 month and extending the period to 3 months gives it a -9.12%, and is -4.84% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.81% over the week and 4.18% over the month.
Organon & Co (OGN) has around 10000 employees, a market worth around $3.70B and $6.40B in sales. Current P/E ratio is 4.30 and Fwd P/E is 3.42. Profit margin for the company is 13.49%. Distance from 52-week low is 3.46% and -37.88% from its 52-week high. The company has generated returns on investments over the last 12 months (9.15%).
with sales reaching $1.54B over the same period.The EPS is expected to shrink by -5.25% this year, but quarterly earnings will post -1.77% year-over-year. Quarterly sales are estimated to shrink -4.89% in year-over-year returns.
Organon & Co (OGN) Top Institutional Holders
The shares outstanding are 257.80M, and float is at 256.85M with Short Float at 7.18%.
The top institutional shareholder in the company is BLACKROCK INC. with over 32.58 million shares valued at $674.39 million. The investor’s holdings represent 12.7414% of the OGN Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 30.21 million shares valued at $625.41 million to account for 11.8161 of the shares outstanding. The other top investors are MASSACHUSETTS FINANCIAL SERVICES CO /MA/ which holds 10.09 million shares representing 3.922% and valued at over $208.88 million, while STATE STREET CORP holds 3.5234 of the shares totaling 9.01 million with a market value of $186.49 million.
Organon & Co (OGN) Insider Activity
A total of 0 insider transactions have happened at Organon & Co (OGN) in the last six months, with sales accounting for 0 and purchases happening 0 times.
Organon & Co (OGN): Who are the competitors?
The company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading 4.65% up over the past 12 months. Pfizer Inc. (PFE) that is 1.39% higher over the same period.
